Topic
GLP-1 receptor agonists
GLP-1 drugs reduce deaths and amputations in patients with diabetes and PAD
New research indicates that GLP-1 receptor agonists can reduce hospitalizations, amputations, and deaths among adults with Type 2 diabetes and peripheral artery disease.